Lifecore Biomedical, Inc. LFCR Cash Flow Statement
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| -$38.72M— | —— | -$99.56M+14.7% | ||
| $8.03M+0.9% | $7.95M-39.6% | $13.18M-27.0% | ||
| $10.16M+63.8% | $6.2M+71.7% | $3.61M+38.5% | ||
| —— | —— | $2.07M+1,489% | ||
| -$7.69M— | —— | $14.85M— | ||
| —— | -$6.68M-141% | $16.42M— | ||
| -$4.81M-391% | $1.65M— | —— | ||
| -$378K+86.9% | -$2.89M-34.2% | -$2.16M— | ||
| —— | -$1.83M— | —— | ||
| $2.26M— | —— | —— | ||
| —— | $257K+101% | -$17.44M+22.8% | ||
| $13.42M-27.1% | $18.4M— | —— | ||
| —— | —— | $0-100% | ||
| -$6.42M+65.1% | -$18.4M-282% | -$4.81M— | ||
| —— | $0-100% | $123.69M+43.1% | ||
| $1.27M+736% | $152K-44.5% | $274K-65.3% | ||
| $6.83M— | —— | $39.7M— | ||
| —— | —— | —— | ||
| —— | —— | —— | ||
| —— | -$18K— | —— | ||
| $2.64M— | $0— | —— | ||
| -$5.92M— | —— | —— | ||
| $2.91M— | —— | —— | ||
| -$378K+86.9% | -$2.89M-34.2% | -$2.16M-413% | ||
| —— | -$1.83M— | —— | ||
| —— | $15.44M— | —— | ||
| —— | $41.9M— | $0— | ||
| —— | —— | $0-100% | ||
| —— | —— | —— | ||
| —— | $146.7M— | —— | ||
| —— | $149.59M— | —— | ||
| —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Lifecore Biomedical, Inc. generate?
- Lifecore Biomedical, Inc. (LFCR) generated $1.5M in operating cash flow over the trailing twelve months.
- What is Lifecore Biomedical, Inc.'s free cash flow?
- After $10.4M of capital expenditures, Lifecore Biomedical, Inc.'s free cash flow was -$9.2M over the trailing twelve months, up 67.2% year over year.
- Where does Lifecore Biomedical, Inc.'s cash flow data come from?
- Every line is extracted from Lifecore Biomedical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
